Alchemystic does not promote, condone, or encourage the illegal or unsupervised use of psychedelic substances. Our services are intended to provide education, support, and integration for individuals engaging in legal, medically supervised psychedelic treatments. We advocate for informed, ethical, and safe practices within the boundaries of the law.
The content on this website is provided for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Alchemystic does not promote, condone, or encourage the illegal or unsupervised use of psychedelic substances. Our services are designed to support individuals engaging in legal, medically supervised ketamine treatments through preparation, education, and integration coaching.

We strongly advocate for informed, ethical, and safe practices within the boundaries of the law.

Alchemystic values your privacy. We do not sell, trade, or share your personal information with third parties. Any data collected through this site is used solely to enhance your experience and to provide you with relevant support and resources.
By Alchemystic LLC
PLEASE READ THESE CUSTOMER TERMS OF SERVICE CAREFULLY.
Alchemystic LLC does not promote the use of any Schedule 1 substance in an unlawful context. Possession and use of various substances remains illegal in the US and in other jurisdictions around the world. Engaging in these activities can carry legal and medical risk. The materials available on this web site are intended for informational purposes only, and not for the purpose of providing legal, medical or mental health care advice. You should contact your attorney, medical or mental health care professional to obtain advice with respect to any particular issue or problem. We acknowledge that use of such substances can present risk and can cause harm.

Regarding references to Psychedelic Assisted Therapy (or PAT), PAT is currently legal in the United States with the use of ketamine by prescription. MDMA, psilocybin, and other substances may be approved by the FDA to treat or manage various diagnoses in the coming years.